Famciclovir Tablet, Film Coated
Product Images NDC 65862-466

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Famciclovir (NDC 65862-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (125 mg (30 Tablet Bottle))

Package Label-principal Display Panel (125 mg (30 Tablet Bottle))
Label for Famciclovir Tablets USP 125 mg, film-coated tablet form, containing 30 tablets per bottle. The label includes storage instructions, distributor information (Aurobindo Pharma USA, Inc.), and a barcode. It specifies the NDC 65862-465-30 and indicates the product is made in India by Aurobindo Pharma Limited.*
FDA Label Image

Package Label-principal Display Panel (125 mg Blister Carton (5 x 10 Unit-dose))

Package Label-principal Display Panel (125 mg Blister Carton (5 x 10 Unit-dose))
Box packaging label for Famciclovir Tablets, USP 125 mg film-coated tablets by Aurobindo Pharma Limited. The unit-dose package contains 50 tablets (5 x 10). The label includes storage instructions, child-resistant packaging notice, and distributor information for Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (250 mg (30 Tablet Bottle))

Package Label-principal Display Panel (250 mg (30 Tablet Bottle))
Label for Famciclovir Tablets USP 250 mg, film-coated tablets. The label indicates a package of 30 tablets, distributed by Aurobindo Pharma USA, Inc. The label includes dosage information, storage conditions, and a barcode.*
FDA Label Image

Package Label-principal Display Panel (250 mg Blister Carton (5 x 10 Unit-dose))

Package Label-principal Display Panel (250 mg Blister Carton (5 x 10 Unit-dose))
Label for Famciclovir Tablets, USP 250 mg, film-coated tablets in unit-dose packaging. The label indicates the strength of 250 mg with a package count of 50 (5 x 10) unit-dose tablets. Distributed by Aurobindo Pharma USA, Inc., and manufactured in India by Aurobindo Pharma Limited. Contains dosage storage instructions and child-resistant packaging information.*
FDA Label Image

Package Label-principal Display Panel (500 mg (30 Tablet Bottle))

Package Label-principal Display Panel (500 mg (30 Tablet Bottle))
Label for Famciclovir Tablets, USP 500 mg, film-coated tablets in a package of 30. The label shows the NDC 65862-467-30 and indicates the product is distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions and dispensing requirements are provided, along with a barcode on the right side.*
FDA Label Image

Package Label-principal Display Panel (500 mg Blister Carton (5 x 10 Unit-dose))

Package Label-principal Display Panel (500 mg Blister Carton (5 x 10 Unit-dose))
Packaging label for Famciclovir Tablets, USP 500 mg film-coated tablets by Aurobindo Pharma Limited. The label indicates a unit-dose package containing 50 tablets (5 x 10). It includes storage instructions, a barcode, and distributor information for Aurobindo Pharma USA, Inc., with the product made in India.*
FDA Label Image

Chemical Structure (Famciclovir Str)

Chemical Structure (Famciclovir Str)
Chemical structure of famciclovir, showing its molecular arrangement including functional groups and ring systems. The diagram displays atoms connected by bonds illustrating the compound's detailed chemical framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.